James Wilbur's Insider Trades & SAST Disclosures
James Wilbur's most recent trade in 10x Genomics Inc - Ordinary Shares - Class A was a trade of 9,699 Class A Common Stock done at an average price of $45.8 . Disclosure was reported to the exchange on Aug. 22, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern James Wilbur.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| 10x Genomics Inc - Ordinar... | James Wilbur | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 45.78 per share. | 22 Aug 2023 | 9,699 | 101,253 (0%) | 0% | 45.8 | 444,031 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | James Wilbur | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 55.07 per share. | 23 May 2023 | 316 | 110,952 (0%) | 0% | 55.1 | 17,401 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | James Wilbur | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2023 | 14,555 | 110,394 (0%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc - Ordinar... | James Wilbur | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2023 | 14,555 | 14,555 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | James Wilbur | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2023 | 7,278 | 7,278 | - | - | Performance-based Restricted Stock Units | |
| 10x Genomics Inc - Ordinar... | James Wilbur | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 239,596 | 239,596 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | James Wilbur | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 95,839 | 95,839 (0%) | 0% | 0 | Class A Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges